Extended Regimens of the Contraceptive Vaginal Ring
- 1 September 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 106 (3), 473-482
- https://doi.org/10.1097/01.aog.0000175144.08035.74
Abstract
To compare the bleeding patterns and tolerability of 3 different extended ring regimens with those of the standard 28-day cycle with 21 days of contraceptive vaginal ring use followed by 7 ring-free days. Following a run-in 28-day ring cycle, women were randomized to 1 of 4 regimens: monthly (28-day cycle), every other month (49-day cycle), every third month (91-day cycle), or continuous (364-day cycle). Treatment duration was 1 year. Daily bleeding diary, interval visit questionnaire, and examination data were collected. A total of 561 women were enrolled, 429 were subsequently randomized, and 289 (67.4%) women completed the entire year. All schedules were well tolerated and acceptable to women, but study completion rates were higher for the shorter cycles. Bleeding days were reduced with postponement of the withdrawal bleeding (ring-free) week, but spotting days increased. For example, women using the continuous or 364-day ring cycle reported a median of zero bleeding days but 10-12 days of spotting during the first 3 months of extended use. Unscheduled bleeding during ring use was the lowest with the traditional 28-day cycle. Adverse events, blood pressure, body weight, and laboratory findings were comparable over the 4 treatment groups. The combination vaginal contraceptive ring can be used for extended cycles to alter the bleeding schedule. Women willing to tolerate some spotting might choose the longer extensions to have fewer menstrual periods. I.Keywords
This publication has 24 references indexed in Scilit:
- A Comparison Between the Vaginal Ring and Oral ContraceptivesObstetrics & Gynecology, 2004
- Why consider vaginal drug administration?Fertility and Sterility, 2004
- The combined contraceptive vaginal ring (NuvaRing®) and lipid metabolism: a comparative studyContraception, 2004
- Ortho Evra™/Evra™ versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing errorFertility and Sterility, 2003
- Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ringObstetrics & Gynecology, 2002
- Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibitionFertility and Sterility, 2001
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activityFertility and Sterility, 1999
- Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptomsObstetrics & Gynecology, 1997
- Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.BMJ, 1977